Učitavanje...

Efficacy of the Triazole SCH 56592 against Leishmania amazonensis and Leishmania donovani in Experimental Murine Cutaneous and Visceral Leishmaniases

Current therapy for leishmaniasis is unsatisfactory. Efficacious and safe oral therapy would be ideal. We examined the efficacy of SCH 56592, an investigational triazole antifungal agent, against cutaneous infection with Leishmania amazonensis and visceral infection with Leishmania donovani in BALB/...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Al-Abdely, Hail M., Graybill, John R., Loebenberg, David, Melby, Peter C.
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology 1999
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC89586/
https://ncbi.nlm.nih.gov/pubmed/10582881
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!